Sep 18, 2019
Dr. Ralph Kern,
Chief Medical Officer, BrainStorm Cell Therapeutics talks about
their late stage clinical programs in treating ALS and MS using
stem cells derived from bone marrow as well as the promise of using
their technology platform to manufacture the cells to develop
therapies for other neurodegenerative diseases like Parkinson's and
Huntington's Disease and autism. While not a cure, this therapy
using repair molecules is focused on stabilizing and preventing
further deterioration.
#BrainStormALS
#BCLI #ALS #EndALS